We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Alere Applauds President’s National Action Plan

Alere Applauds President’s National Action Plan

Alere Applauds President’s National Action Plan

Alere Applauds President’s National Action Plan

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Alere Applauds President’s National Action Plan"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Alere Inc. has issued the following statement in support of President Barack Obama’s National Action Plan to Combat Antibiotic-Resistant Bacteria.

“As the global leader in rapid diagnostics for infectious disease, we commend President Barack Obama for establishing a National Action Plan with measurable goals and specific milestones to address the serious threat of antibiotic resistance. We look forward to continuing to work with the Administration on initiatives to promote the development of rapid point-of-care tests that, in turn, help reduce the misuse of antibiotics and unnecessary health care spending,” said Avi Pelossof, Alere Global President, Infectious Disease.

The National Action Plan to Combat Antibiotic-Resistant Bacteria outlines Federal activities over the next five years to enhance domestic and international capacity to prevent and contain outbreaks of antibiotic-resistant infections; develop and deploy next-generation diagnostics, antibiotics, vaccines, and other therapeutics; and maintain the efficacy of current and new antibiotics.

For more information on the National Action Plan, go to

In partnership with the Alliance for the Prudent Use of Antibiotics (APUA), Alere has established Test. Target. Treat™, an antimicrobial stewardship initiative that provides tools and diagnostic strategies to support clinicians and increase global awareness of antibiotic resistance and effective interventions.